161 related articles for article (PubMed ID: 21426318)
1. Both stimulation of GLP-1 receptors and inhibition of glycogenolysis additively contribute to a protective effect of oral miglitol against ischaemia-reperfusion injury in rabbits.
Iwasa M; Yamada Y; Kobayashi H; Yasuda S; Kawamura I; Sumi S; Shiraki T; Yamaki T; Ushikoshi H; Hattori A; Aoyama T; Nishigaki K; Takemura G; Fujiwara H; Minatoguchi S
Br J Pharmacol; 2011 Sep; 164(1):119-31. PubMed ID: 21426318
[TBL] [Abstract][Full Text] [Related]
2. Antidiabetic drug voglibose is protective against ischemia-reperfusion injury through glucagon-like peptide 1 receptors and the phosphoinositide 3-kinase-Akt-endothelial nitric oxide synthase pathway in rabbits.
Iwasa M; Kobayashi H; Yasuda S; Kawamura I; Sumi S; Yamada Y; Shiraki T; Yamaki T; Ushikoshi H; Aoyama T; Nishigaki K; Takemura G; Fujiwara T; Fujiwara H; Minatoguchi S
J Cardiovasc Pharmacol; 2010 Jun; 55(6):625-34. PubMed ID: 20351564
[TBL] [Abstract][Full Text] [Related]
3. Antidiabetic drug miglitol inhibits myocardial apoptosis involving decreased hydroxyl radical production and Bax expression in an ischaemia/reperfusion rabbit heart.
Wang N; Minatoguchi S; Chen X; Uno Y; Arai M; Lu C; Takemura G; Fujiwara T; Fujiwara H
Br J Pharmacol; 2004 Jul; 142(6):983-90. PubMed ID: 15210576
[TBL] [Abstract][Full Text] [Related]
4. A novel anti-diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits.
Minatoguchi S; Arai M; Uno Y; Kariya T; Nishida Y; Hashimoto K; Kawasaki M; Takemura G; Fujiwara T; Fujiwara H
Br J Pharmacol; 1999 Dec; 128(8):1667-72. PubMed ID: 10588921
[TBL] [Abstract][Full Text] [Related]
5. The anti-diabetic drug miglitol is protective against anginal ischaemia through a mechanism independent of regional myocardial blood flow in the dog.
Uno Y; Minatoguchi S; Arai M; Wang N; Chen XH; Hashimoto K; Lu C; Takemura G; Fujiwara H
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):805-10. PubMed ID: 16173940
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning.
Basalay MV; Mastitskaya S; Mrochek A; Ackland GL; Del Arroyo AG; Sanchez J; Sjoquist PO; Pernow J; Gourine AV; Gourine A
Cardiovasc Res; 2016 Dec; 112(3):669-676. PubMed ID: 27702763
[TBL] [Abstract][Full Text] [Related]
7. Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat.
Bao W; Holt LJ; Prince RD; Jones GX; Aravindhan K; Szapacs M; Barbour AM; Jolivette LJ; Lepore JJ; Willette RN; DeAngelis E; Jucker BM
Cardiovasc Diabetol; 2013 Oct; 12():148. PubMed ID: 24125539
[TBL] [Abstract][Full Text] [Related]
8. Combination of miglitol, an anti-diabetic drug, and nicorandil markedly reduces myocardial infarct size through opening the mitochondrial K(ATP) channels in rabbits.
Minatoguchi S; Wang N; Uno Y; Arai M; Hashimoto K; Hashimoto Y; Chen XH; Takemura G; Fujiwara H
Br J Pharmacol; 2001 Aug; 133(7):1041-6. PubMed ID: 11487514
[TBL] [Abstract][Full Text] [Related]
9. Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction.
Yasuda S; Kobayashi H; Iwasa M; Kawamura I; Sumi S; Narentuoya B; Yamaki T; Ushikoshi H; Nishigaki K; Nagashima K; Takemura G; Fujiwara T; Fujiwara H; Minatoguchi S
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1558-65. PubMed ID: 19286954
[TBL] [Abstract][Full Text] [Related]
10. Signalling pathways activated by glucagon-like peptide-1 (7-36) amide in the rat heart and their role in protection against ischaemia.
Huisamen B; Genade S; Lochner A
Cardiovasc J Afr; 2008; 19(2):77-83. PubMed ID: 18516352
[TBL] [Abstract][Full Text] [Related]
11. Antidiabetic Drug Alogliptin Protects the Heart Against Ischemia-reperfusion Injury Through GLP-1 Receptor-dependent and Receptor-independent Pathways Involving Nitric Oxide Production in Rabbits.
Baba S; Iwasa M; Higashi K; Minatoguchi S; Yamada Y; Kanamori H; Kawasaki M; Nishigaki K; Minatoguchi S
J Cardiovasc Pharmacol; 2017 Dec; 70(6):382-389. PubMed ID: 28817485
[TBL] [Abstract][Full Text] [Related]
12. Miglitol administered before breakfast increased plasma active glucagon-like peptide-1 (GLP-1) levels after lunch in patients with type 2 diabetes treated with sitagliptin.
Aoki K; Kamiyama H; Yoshimura K; Shibuya M; Masuda K; Terauchi Y
Acta Diabetol; 2012 Jun; 49(3):225-30. PubMed ID: 21898126
[TBL] [Abstract][Full Text] [Related]
13. Design and evaluation of oral bioadhesive controlled release formulations of miglitol, intended for prolonged inhibition of intestinal alpha-glucosidases and enhancement of plasma glucagon like peptide-1 levels.
Deshpande MC; Venkateswarlu V; Babu RK; Trivedi RK
Int J Pharm; 2009 Oct; 380(1-2):16-24. PubMed ID: 19563873
[TBL] [Abstract][Full Text] [Related]
14. The intestine responds to heart failure by enhanced mitochondrial fusion through glucagon-like peptide-1 signalling.
Naruse G; Kanamori H; Yoshida A; Minatoguchi S; Kawaguchi T; Iwasa M; Yamada Y; Mikami A; Kawasaki M; Nishigaki K; Minatoguchi S
Cardiovasc Res; 2019 Nov; 115(13):1873-1885. PubMed ID: 30629149
[TBL] [Abstract][Full Text] [Related]
15. Postconditioning with curaglutide, a novel GLP-1 analog, protects against heart ischemia-reperfusion injury in an isolated rat heart.
Salling HK; Döhler KD; Engstrøm T; Treiman M
Regul Pept; 2012 Oct; 178(1-3):51-5. PubMed ID: 22749991
[TBL] [Abstract][Full Text] [Related]
16. Effects of pre-meal versus post-meal administration of miglitol on plasma glucagon-like peptide-1 and glucosedependent insulinotropic polypeptide levels in healthy men.
Aoki K; Miyazaki T; Nagakura J; Orime K; Togashi Y; Terauchi Y
Endocr J; 2010; 57(8):673-7. PubMed ID: 20519807
[TBL] [Abstract][Full Text] [Related]
17. DPP4 deficiency preserves cardiac function via GLP-1 signaling in rats subjected to myocardial ischemia/reperfusion.
Ku HC; Chen WP; Su MJ
Naunyn Schmiedebergs Arch Pharmacol; 2011 Aug; 384(2):197-207. PubMed ID: 21748358
[TBL] [Abstract][Full Text] [Related]
18. Exendin-4 attenuates myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein expression.
Hu G; Zhang Y; Jiang H; Hu X
Cardiol J; 2013; 20(6):600-4. PubMed ID: 24338536
[TBL] [Abstract][Full Text] [Related]
19. The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics.
Lee A; Patrick P; Wishart J; Horowitz M; Morley JE
Diabetes Obes Metab; 2002 Sep; 4(5):329-35. PubMed ID: 12190996
[TBL] [Abstract][Full Text] [Related]
20. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
